Analysis of TTN Truncating Variants in >74 000 Cases Reveals New Clinically Relevant Gene Regions
Authors:
- Matteo VattaMVMatteo Vatta
- Ellen RegaladoEREllen Regalado
- Michael ParfenovMPMichael Parfenov
- Dan SwartzlanderDSDan Swartzlander
- Andrea NaglANAndrea Nagl
- Meghan MannelloMMMeghan Mannello
- Rachel LewisRLRachel Lewis
- Daniel ClemensDCDaniel Clemens
- John GarciaJGJohn Garcia
- Rachel E. EllsworthRachel E. Ellsworth
- Ana MoralesAMAna Morales
- Yi-Lee TingYTYi-Lee Ting
Open Access
- 1 April 2025
- journal article
- Published by Wolters Kluwer Health in Circulation: Genomic and Precision Medicine
- Vol. 18 (2) , e004982
Abstract
BACKGROUND: Truncating variants (TTNtvs) in the titin ( TTN ) gene have been associated with cardiomyopathies or arrhythmias (C/A) and autosomal recessive neuromuscular diseases (NM). However, the clinical significance of TTNtvs across the entire coding sequence of TTN has not been comprehensively assessed. The purpose of this study was to examine the burden of TTNtvs in C/A and NM cases compared with controls in the genome aggregation database. METHODS: This was a retrospective study of probands who underwent multigene testing (49 740 C/A panel, 24 514 NM panel) that included TTN from November 2017 to October 2021. Burden testing was performed using controls in the genome aggregation database v3.1.2 database, and the analysis was stratified by exon/band location and exon usage in cardiac or skeletal muscle. Frequency and odds ratio of TTNtv alleles in C/A or NM cases and genome aggregation database controls were measured. RESULTS: There were 2446 (4.9%) C/A and 482 (2.0%) NM cases with 2446 and 528 TTNtv alleles, respectively. TTNtvs in all bands were significantly enriched in both C/A and NM cases compared with controls. A significant enrichment of TTNtvs in C/A was observed for exon 358 of the M-band (odds ratio, 2.55 [95% CI, 1.85–3.54]) but not the other M-band exons. CONCLUSIONS: In the largest single-site cohort of C/A and NM cases with TTNtvs, an enrichment of TTNtvs across TTN was observed. These findings expand the clinically relevant regions of TTN .Keywords
This publication has 36 references indexed in Scilit:
- Skeletal Muscle Involvement in Patients With Truncations of Titin and Familial Dilated CardiomyopathyJACC: Heart Failure, 2023
- Association of Titin Variations With Late-Onset Dilated CardiomyopathyJAMA Cardiology, 2022
- Novel heterozygous truncating titin variants affecting the A‐band are associated with cardiomyopathy and myopathy/muscular dystrophyMolecular Genetics & Genomic Medicine, 2020
- A novel TTN deletion in a family with skeletal myopathy, facial weakness, and dilated cardiomyopathyMolecular Genetics & Genomic Medicine, 2019
- Interpreting Genetic Variants in Titin in Patients With Muscle DisordersJAMA Neurology, 2018
- A Systematic Comparison of Traditional and Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Genes in More Than 1000 PatientsThe Journal of Molecular Diagnostics, 2015
- Titin mutations: the fall of GoliathHeart Failure Reviews, 2015
- A Rising Titan:TTNReview and Mutation UpdateHuman Mutation, 2014
- Sense and stretchability: The role of titin and titin-associated proteins in myocardial stress-sensing and mechanical dysfunctionCardiovascular Research, 2008
- Identification of a novel frameshift mutation in the giant muscle filament titin in a large Australian family with dilated cardiomyopathyJournal of Molecular Medicine, 2006